Montgomery B - Search Results

1

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.

Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange PH, Shendure J, Vessella RL, Nelson PS. Kumar A, et al. Among authors: montgomery b. Nat Med. 2016 Apr;22(4):369-78. doi: 10.1038/nm.4053. Epub 2016 Feb 29. Nat Med. 2016. PMID: 26928463 Free PMC article.

2

Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.

Bonham M, Arnold H, Montgomery B, Nelson PS. Bonham M, et al. Among authors: montgomery b. Cancer Res. 2002 Jul 15;62(14):3920-4. Cancer Res. 2002. PMID: 12124319

3

Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.

Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D, Nelson PS. Bonham MJ, et al. Among authors: montgomery b. J Natl Cancer Inst. 2002 Nov 6;94(21):1641-7. doi: 10.1093/jnci/94.21.1641. J Natl Cancer Inst. 2002. PMID: 12419791

4

Unconventional therapy for prostate cancer: good, bad or questionable?

Nelson PS, Montgomery B. Nelson PS, et al. Among authors: montgomery b. Nat Rev Cancer. 2003 Nov;3(11):845-58. doi: 10.1038/nrc1210. Nat Rev Cancer. 2003. PMID: 14668815 Review. No abstract available.

5

Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma.

Bonham M, Posakony J, Coleman I, Montgomery B, Simon J, Nelson PS. Bonham M, et al. Among authors: montgomery b. Clin Cancer Res. 2005 May 15;11(10):3905-14. doi: 10.1158/1078-0432.CCR-04-1974. Clin Cancer Res. 2005. PMID: 15897592

6

Cell type-specific analyses for identifying prostate cancer biomarkers.

Nelson PS, Montgomery B. Nelson PS, et al. Among authors: montgomery b. Curr Urol Rep. 2006 Jan;7(1):57-63. doi: 10.1007/s11934-006-0039-4. Curr Urol Rep. 2006. PMID: 16480670 Review.

7

The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy.

Mitsuyama H, Wallner K, Merrick G, Virgin J, Orio P, Montgomery B, True LD. Mitsuyama H, et al. Among authors: montgomery b. Am J Clin Oncol. 2007 Dec;30(6):597-600. doi: 10.1097/COC.0b013e318145b9ba. Am J Clin Oncol. 2007. PMID: 18091053

8

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

Harris WP, Mostaghel EA, Nelson PS, Montgomery B. Harris WP, et al. Among authors: montgomery b. Nat Clin Pract Urol. 2009 Feb;6(2):76-85. doi: 10.1038/ncpuro1296. Nat Clin Pract Urol. 2009. PMID: 19198621 Free PMC article. Review.

9

Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.

Mostaghel EA, Montgomery B, Nelson PS. Mostaghel EA, et al. Among authors: montgomery b. Urol Oncol. 2009 May-Jun;27(3):251-7. doi: 10.1016/j.urolonc.2009.03.016. Urol Oncol. 2009. PMID: 19414113 Free PMC article. Review.

10

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.

Montgomery B, Nelson PS, Vessella R, Kalhorn T, Hess D, Corey E. Montgomery B, et al. BMC Cancer. 2010 May 28;10:244. doi: 10.1186/1471-2407-10-244. BMC Cancer. 2010. PMID: 20509933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

686 results

Search Page